Sunniva Inc. Closes $23.0 Million Bought Deal Public Offering and Provides Operational Update
VANCOUVER, Oct. 12, 2018 /CNW/ – Sunniva Inc. (“Sunniva” or the “Company”) (CSE: SNN) (OTCQX: SNNVF) is pleased to announce that it has completed its bought deal public offering (the “Offering”) for aggregate gross proceeds of $23,029,900 (All figures are in Canadian dollars unless otherwise stated). A total of 4,370,000 units (the “Units”) of the Company were sold pursuant to the Offering, including 570,000 Units issued as a result of the full exercise of the Underwriters’ over-allotment option, at a price of $5.27 per Unit. The Offering was conducted by a syndicate of underwriters co-led by Beacon Securities Limited and Canaccord Genuity Corp. and including Haywood Securities Inc.
Each Unit consists of one common share (a “Common Share”) in the capital of the Company and one-half (1/2) of one Common Share purchase warrant (each whole warrant, a “Warrant”) of the Company. Each Warrant entitles the holder thereof to acquire one Common Share at an exercise price of $6.85 per Common Share for a period of 24 months from the closing of the Offering.
The Company intends to use the majority of the net proceeds of the Offering to fund ongoing development at the Sunniva Canada Campus greenhouse facility in Okanagan Falls, British Columbia and the Sunniva California Campus greenhouse facility in Cathedral City, California. It is intended that the remaining net proceeds of the Offering will be used by the Company for working capital and general corporate purposes.
The Units issued under the Offering were offered by way of a short form prospectus dated October 4, 2018 (the “Prospectus”) filed in the provinces of British Columbia, Alberta and Ontario and were offered in the United States to Qualified Institutional Buyers pursuant to exemptions from the registration requirements under rule 144A of the United States Securities Act of 1933, as amended, in a manner that does not require the Units to be registered in the United States. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor in any other jurisdiction.
Significant progress has been made towards the completion of construction of the Sunniva California Campus, a 489,000 square foot purpose built greenhouse cultivation facility in Cathedral City, California and early stage construction continues at the 759,000 square foot Sunniva Canada Campus facility in Okanagan Falls, British Columbia.
In California, Sunniva is now at the point of advancing its business model, moving quickly up the value chain leveraging our cultivation and extraction assets and launching Sunniva brands across all major product categories including pre-rolls, vaporizers and filled cartridges, flower, concentrates, and beverages, while aggressively pursuing distribution and retail dispensary expansion.
In Canada, Sunniva has retained Canaccord Genuity Corp., who has commenced a formal process to review all strategic alternatives which may include a sale of, an investment in, or a joint venture for some or all of the Company’s Canadian assets with the intention to spin out the Company’s Canadian assets into a separate Canadian entity and apply to list its shares on the Toronto Stock Exchange and the NASDAQ Stock Market.
Milestones and objectives that the Company is targeting over the next 12 months include:
Please see the updated Corporate Presentation and Fact Sheet at www.Sunniva.com/Investors/
About Sunniva Inc.
Sunniva, through its subsidiaries, is a vertically integrated cannabis company operating in the world’s two largest cannabis markets – Canada and California. Our ability to leverage our large-scale, purpose-built cGMP designed greenhouses, offering better quality assurance with cannabis products free from pesticides, uniquely positions Sunniva as a leading supplier of safe, high quality products at scale. Through strategically positioned cultivation and extraction facilities, Sunniva intends to launch a suite of branded products in various product categories including flower, pre-rolls, beverages, vape cartridges, extracts while beginning to pursue upstream opportunities including distribution and retail expansion. Sunniva’s management and board of directors have a proven track record for creating significant shareholder value both in the healthcare and biotech industries.
For more information please visit: www.sunniva.com.
Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.